Previously, viable chimeric flaviviruses were constructed that contained tick-borne encephalitis virus (TBEV) CME or ME structural protein genes with the remaining genes derived from dengue type 4 virus (DEN4). The ME chimera retained the neurovirulence for mice of its TBEV parent from which its M and E genes were derived, but it lacked the peripheral invasiveness of TBEV. Later, neurovirulence demonstrable by intracerebral (IC) inoculation was reduced or ablated by a single mutation introduced into the M, E or NS1 of the chimera. These mutations also caused a restriction in replication in simian and mosquito cells. Nonetheless, parenteral inoculation of these attenuated mutants induced complete resistance in mice to fatal encephalitis caused by the neurovirulent ME chimera. This suggests a new strategy for developing a live attenuated TBEV vaccine. Langat (LGT) virus (TP21 strain) is the least virulent of all TBEV-complex flaviviruses. It has not been associated with any human disease. The sequence of wild type virus (TP21 strain) and a more attenuated strain of LGT derived from it (strain E5) were determined. Comparison of these sequences with other TBEV indicated that there is an inverse relationship between the length of the 3' noncoding region and the virulence of TBEV flaviviruses for humans and animals. Analysis of the TP21 and E5 genome sequences revealed only 11 amino acid differences in the polyprotein. We recovered two viable chimeric viruses that contained prM and E genes of LGT virus strain TP21 or E5 and all other sequences from DEN4. These chimeras differed in their LGT-derived sequences at only four amino acid positions in the E protein. In contrast to parental TP21, E5 and DEN4 viruses, chimeric TP21/DEN4 and E5/DEN4 viruses were restricted in growth in primate cells and did not form plaques. Studies in suckling mice inoculated IC with the TP21/DEN4 or E5/DEN4 chimera indicated that these viruses retained the low neurovirulence of their DEN4 parent rather than the higher neurovirulence of their LGT virus parent. Similarly, the LGT/DEN4 chimeric viruses exhibited little if any of the peripheral invasiveness of their LGT parent. A high titer of neutralizing antibodies developed in these mice which were resistant to subsequent peripheral challenge with 1000 IP LD50 of wild type LGT virus. We conclude that (i) the LGT E protein (and possibly the M protein) represents the major protective antigen(s), which induces resistance to lethal LGT challenge, and (ii) proteins encoded by other regions of the LGT genome are required for LGT to spread from a peripheral site to the brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000637-05
Application #
2566837
Study Section
Special Emphasis Panel (LID)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Maximova, Olga A; Faucette, Lawrence J; Ward, Jerrold M et al. (2009) Cellular inflammatory response to flaviviruses in the central nervous system of a primate host. J Histochem Cytochem 57:973-89
Blaney Jr, Joseph E; Speicher, James; Hanson, Christopher T et al. (2008) Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys. Vaccine 26:4150-9
Maximova, Olga A; Ward, Jerrold M; Asher, David M et al. (2008) Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J Virol 82:5255-68
Wright, Peter F; Ankrah, Sharon; Henderson, Susan E et al. (2008) Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers. Vaccine 26:882-90
Pletnev, Alexander G; Swayne, David E; Speicher, Jim et al. (2006) Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 24:6392-404
Rumyantsev, Alexander A; Murphy, Brian R; Pletnev, Alexander G (2006) A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice. J Virol 80:1427-39
Rumyantsev, Alexander A; Chanock, Robert M; Murphy, Brian R et al. (2006) Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine 24:133-43
Hanley, Kathryn A; Goddard, Laura B; Gilmore, Lara E et al. (2005) Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors. Vector Borne Zoonotic Dis 5:1-10
Pletnev, Alexander G; Claire, Marisa St; Elkins, Randy et al. (2003) Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 314:190-5
Pletnev, Alexander G; Putnak, Robert; Speicher, Jim et al. (2002) West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci U S A 99:3036-41

Showing the most recent 10 out of 15 publications